慢性肠道炎症促进肝癌的发展
作者:
基金项目:

973课题"细胞微环境在肿瘤发生发展及侵袭转移中的作用及机制"(2011CB504205)。


Chronic colitis induced by irritant dextran sodium sulphate promote hepatoma development in mice
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [21]
  • | | | |
  • 文章评论
    摘要:

    目的 探讨慢性肠道炎症状态下菌群结构及构成改变对肝癌进展的影响。方法 22只雄性乙肝病毒转基因小鼠在出生后第2周腹腔注射二乙基亚硝胺诱导小鼠原发性肝癌, 随机分为慢性肠炎组(给予含2%葡聚糖硫酸钠的饮用水)和对照组(给予正常饮用水)。上述小鼠观察至22周龄。在此期间定期进行肝功能测定, 收集粪便进行宏基因组测序。另将4只已发生肝癌的小鼠与7只8周龄肉眼及病理学未见肝癌的小鼠同笼(分2笼)饲养16周。结果 DSS所诱导的慢性肠炎小鼠与正常饮用水小鼠相比肝功能无显著改变;DSS诱导的慢性肠炎组小鼠(n=10)在第22周龄时有9只发生弥漫性肉眼可见的肝癌, 而正常饮用水小鼠(n=12)仅有2只发生肝癌, 肿瘤发生率(P=0.002)和肿瘤数量(P=0.028)有显著差别;与正常饮用水小鼠相比, 慢性肠炎组小鼠肠道菌群中, 普雷沃氏菌属(P=0.022)和厌氧支原体属(P=0.014)显著减少;与已发生肝癌小鼠进行同笼饲养的小鼠(n=7)在24周龄时全部发生肉眼可见的肝癌。结论 慢性肠道炎症状态下, 肠道菌群改变可促进肝癌进展。

    Abstract:

    Objective To investigate the effect of gut bacteria under chronic colitis on the progression of hepatoma in mice. Methods 22 hepatitis B virus (HBV)-transgenic mice (male, 8 weeks) were randomly divided into two groups, one group (n=10) was fed the drinking water containing 2% dextran sodium sulphate(DSS)to induce chronic colitis and the control group(n=12)was fed with normal drinking water. In order to investigate the effect of gut microbes, 7 male HBV-transgenic mice(8 weeks, with no detectable hepatoma under microscopy) were cohoused with 4 mice with hepatoma for 16 weeks. Results No significant liver cell damage was observed in the group of the mice fed with 2% DSS-containing drinking water. By the 22-week old, 9 of the 10 mice(90.0%) fed with 2% DSS-containing drinking water, 2 of the 12 mice(16.7%) fed with normal drinking had hepatoma. Both the hepatoma incidence and the tumor numbers in the group of mice fed with DSS-containing water were significantly higher than that in the controls (P=0.002 and P=0.028respetively). Compared to controls, the bacteria family Prevotella (P=0.022) and Anaeroplasma (P=0.014) reduced significantly in the mice with induced chronic colitis. All the mice (n=7) cohoused with the mice with hepatoma had the liver tumor developed at 24-week-old. Conclusion Alterations of gut bacteria under chronic colitis may promote the development of liver cancer.

    参考文献
    [1] Poon D., Anderson B. O., Chen L. T., et al. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009[J]. Lancet Oncol, 2009, 10(11):1111-1118.
    [2] Tanaka M., Katayama F., Kato H., et al. Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures[J]. J Epidemiol, 2011, 21(6):401-416.
    [3] Zhang Y., Ren J. S., Shi J. F., et al. International trends in primary liver cancer incidence from 1973 to 2007[J]. BMC Cancer, 2015, 15(1):1113.
    [4] Chang M. H., You S. L., Chen C. J., et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study[J]. J Natl Cancer Inst, 2009, 101(19):1348-1355.
    [5] Chiang C. J., Yang Y. W., You S. L., et al. Thirty-year outcomes of the national hepatitis B immunization program in Taiwan[J]. JAMA, 2013, 310(9):974-976.
    [6] Chien Y. C., Jan C. F., Chiang C. J., et al. Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: A 20-year cohort study of 3.8 million vaccinees[J]. Hepatology, 2014, 60(1):125-132.
    [7] Qu C., Chen T., Fan C., et al. Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial[J]. PLoS Med, 2014, 11(12):e1001774.
    [8] Sun Z., Chen T., Thorgeirsson S. S., et al. Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China[J]. Carcinogenesis, 2013, 34(8):1800-1805.
    [9] Chen J. G., Egner P. A., Ng D., et al. Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China[J]. Cancer Prev Res (Phila), 2013, 6(10):1038-1045.
    [10] Mendoza J. L., Lana R., Taxonera C., et al. Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis[J]. Med Clin (Barc), 2005, 125(8):297-300.
    [11] Vesselinovitch S. D., Mihailovich N. Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse[J]. Cancer Res, 1983, 43(9):4253-4259.
    [12] Druckrey H., Steinhoff D., Preussmann R., et al. Induction of Cancer by a Single Dose of Methylnitroso-Urea and Various Dialkylnitrosamines in Rats[J]. Z Krebsforsch, 1964, 66(1-10.
    [13] Ohkusa T. Production of experimental ulcerative colitis in hamsters by dextran sulfate sodium and changes in intestinal microflora[J]. Nihon Shokakibyo Gakkai Zasshi, 1985, 82(5):1327-1336.
    [14] Guarner F., Malagelada J. R. Gut flora in health and disease[J]. Lancet, 2003, 361(9356):512-519.
    [15] O'Keefe S. J. Nutrition and colonic health: the critical role of the microbiota[J]. Curr Opin Gastroenterol, 2008, 24(1):51-58.
    [16] Rawls J. F., Samuel B. S., Gordon J. I. Gnotobiotic zebrafish reveal evolutionarily conserved responses to the gut microbiota[J]. Proc Natl Acad Sci U S A, 2004, 101(13):4596-4601.
    [17] Rogers A. B. Distance burning: how gut microbes promote extraintestinal cancers[J]. Gut Microbes, 2011, 2(1):52-57.
    [18] Darnaud M., Faivre J., Moniaux N. Targeting gut flora to prevent progression of hepatocellular carcinoma[J]. J Hepatol, 2013, 58(2):385-387.
    [19] Dapito D. H., Mencin A., Gwak G. Y., et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4[J]. Cancer Cell, 2012, 21(4):504-516.
    [20] Elinav E., Thaiss C. A., Flavell R. A. Analysis of microbiota alterations in inflammasome-deficient mice[J]. Methods Mol Biol, 2013, 1040(185-194.
    [21] Damman C. J., Miller S. I., Surawicz C. M., et al. The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation?[J]. Am J Gastroenterol, 2012, 107(10):1452-1459.
    相似文献
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

易宏淦,臧梦雅,吴志远,朱正,赵新明,王维虎,曲春枫.慢性肠道炎症促进肝癌的发展[J].中国比较医学杂志,2015,25(5):1~4.

复制
分享
文章指标
  • 点击次数:2147
  • 下载次数: 1728
  • HTML阅读次数: 0
  • 引用次数: 0
历史
  • 最后修改日期:2015-03-31
  • 在线发布日期: 2015-05-29
防诈骗提示!请勿点击不明链接或添加个人微信。编辑部所有邮箱后缀均为@cnilas.org
关闭